DOCSLIB.ORG

Prescription Drug List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prescription Drug List Kaiser Permanente Hawaii PRESCRIPTION DRUG LIST Four-tier drug benefit This formulary list provides coverage information about the drugs covered under our Four-Tier Pharmacy Plan. The list is organized in alphabetical order and each drug name includes a color box that shows which tier the drug falls within. If your prescription drug is not on this list, it is not covered under our four-tier benefit structure. TIER 1 TIER 2 TIER 3 TIER 4 Generic drugs Generic drugs Brand-name drugs Specialty drugs on the published list. not included in Tier 1. on the published list. on the published list. Under the four-tier benefit structure, you pay a lower copayment for medically necessary generic medications and a higher copayment for specialty medications. Your copayments depend on your plan. For information about your prescription copayments, please review your Summary of Benefits. If your physician has prescribed a medically necessary generic medication, but you prefer to have the brand-name drug, you will pay the full member rate for the brand-name medication. Certain drugs may deviate from the four-tier benefit structure. See the following definitions for abbreviations linked to certain drugs on this list: • ACA = Under the Affordable Care Act (ACA), certain over-the-counter and prescription drugs are covered at no charge when prescribed by a physician for preventative purposes. • HCR = Certain Food and Drug Administration-approved contraceptive drugs and devices are available at no charge under health care reform (HCR). • PAH = There are some drugs that are covered only for pulmonary arterial hypertension (PAH). • TC = There are no charges for approved tobacco cessation (TC) products. This drug list is subject to change and drugs may be added or removed without notice. Some drugs fall in different tiers depending on strength and dosage form. For the most up-to-date listing of formulary drugs, including strengths and dosage forms available, visit kp.org/formulary and select “Covered drugs in your area”. You’ll find the Kaiser Permanente Hawaii Drug Formulary under the “Our formularies” section. Check back often for updates. QUESTIONS? Please contact your employer or call Member Services at 1-800-966-5955, Monday through Friday, 8 a.m. to 5 p.m., and Saturday, 8 a.m. to noon. For the deaf, hard of hearing, or speech impaired, call TTY 711. 7003MEM-17 | KAH2927 | September 2017 A ¢ Aminosalicylic ¢ Benazepril ¢ Canagliflozin ¢ Abacavir ¢ Amiodarone ¢ Benzonatate ¢ Canakinumab ¢ Abacavir-Dolutegravir- ¢ Amitriptyline ¢ Benzoyl peroxide-erythromycin ¢ Candesartan Lamivudine ¢ Amlexanox ¢ Benztropine ¢ Capecitabine ¢ Abacavir-Lamivudine ¢ Amlodipine ¢ Benztropine 2mg ¢ Captopril ¢ Abacavir-Lamivudine-Zidovudine ¢ Amoxapine ¢ Benzyl alcohol ¢ Carbamazepine 100mg ¢ Abatacept ¢ Amoxicillin-Clavulanate ¢ Bepotastine extended release tablet ¢ Abiraterone ¢ Amoxicillin ¢ Besifloxacin ¢ Carbamazepine ¢ Acamprosate ¢ Amphetamine- ¢ Betamethasone ¢ Carbidopa ¢ Acarbose Dextroamphetamine ¢ Betaxolol ¢ Carbidopa-Levodopa ¢ Acebutolol ¢ Ampicillin ¢ Bethanechol ¢ Carbinoxamine ¢ Acetaminophen-Caffeine- ¢ Anagrelide ¢ Bexarotene capsule ¢ Carisoprodol Dihydrocodeine ¢ Anakinra ¢ Bexarotene gel ¢ Carteolol ¢ Acetaminophen-Codeine ¢ Anastrozole ¢ Bicalutamide ¢ Carvedilol tablet ¢ Acetazolamide ¢ Antipyrine-Benzocaine ¢ Bimatoprost ¢ Carvedilol suspension ¢ Acetic acid ¢ Apomorphine ACA Bisacodyl ¢ Cefaclor ¢ Acetohydroxamic acid ¢ Apraclonidine ¢ Bisoprolol ¢ Cefadroxil ¢ Acetylcysteine ¢ Apremilast ¢ Bisoprolol-Hydrochlorothiazide ¢ Cefazolin ¢ Acitretin ¢ Aprepitant ¢ Boceprevir ¢ Cefdinir ¢ Acyclovir ¢ Arformoterol ¢ Bosentan ¢ Cefditoren ¢ Adalimumab ¢ Aripiprazole ¢ Bosutinib ¢ Cefixime ¢ Adapalene ¢ Armodafinil ¢ Brimonidine ophthalmic solution ¢ Cefpodoxime ¢ Adapalene-Benzoyl peroxide ¢ Artemether-Lumefantrine ¢ Brimonidine topical gel ¢ Cefprozil ¢ Adefovir ¢ Artificial tear ophthalmic ¢ Brimonidine-Timolol ¢ Ceftibuten ¢ Albendazole ¢ Asenapine ¢ Brinzolamide ¢ Cefuroxime ¢ Albuterol tablet ACA Aspirin ¢ Bromfenac ¢ Celecoxib ¢ Albuterol 2mg/5ml syrup ¢ Aspirin-Extended release ¢ Bromocriptine 0.8mg tablet ¢ Cephalexin ¢ Albuterol 0.083% dipyridamole ¢ Ceradroxil inhalation solution ¢ Bromocriptine 2.5mg tablet ¢ Atazanavir ¢ Budesonide capsule ¢ Certolizumab ¢ Albuterol 0.5% ¢ Atenolol inhalation solution ¢ Budesonide inhalation ¢ Cevimeline ¢ Atenolol suspension ¢ Albuterol 1.25mg/3ml suspension ¢ Chlorambucil inhalation solution ¢ Atomoxetine ¢ Budesonide 9mg tablet ¢ Chlordiazepoxide ¢ Albuterol 108mcg-actuation ¢ Atorvastatin ¢ Bumetanide ¢ Chlordiazepoxide-Clidinium inhaler ¢ Atovaquone ¢ Buprenorphine patch ¢ Chlorhexidine ¢ Alcaftadine ¢ Atovaquone-Proguanil ¢ Buprenorphine sublingual tablet ¢ Chloroquine ¢ Alclometasone ¢ Atropine ¢ Buprenorphine-Naloxone ¢ Chlorothiazide ¢ Alendronate ¢ Axitinib ¢ Bupropion ¢ Chlorpromazine ¢ Alfuzosin ¢ Azathioprine TC Bupropion 150mg ¢ Chlorpropamide ¢ Aliskiren ¢ Azelaic sustained release tablet ¢ Chlorthalidone ¢ Alitretinoin ¢ Azelastine ¢ Buspirone ¢ Chlorzoxazone ¢ Allopurinol ¢ Azelastine-Fluticasone ¢ Buspirone 5mg, 10mg tablet ACA Cholecalciferol ¢ Almotriptan ¢ Azilsartan ¢ Butalbital-Acetaminophen- ¢ Cholestyramine ¢ Alosetron ¢ Azithromycin Caffeine ¢ Choriogonadotropin alfa ¢ Alprazolam ¢ Azithromycin ophthalmic ¢ Butalbital-Aspirin-Caffeine ¢ Ciclesonide ¢ Altretamine solution ¢ Butamben-Tetracaine- ¢ Ciclopirox ¢ Benzocaine ¢ Aluminum acetate-Acetic acid Aztreonam ¢ Cilostazol ¢ Aluminum chloride B C ¢ Cimetidine ¢ Cabozantinib ¢ Alvimopan ¢ Bacitracin ¢ Cinacalcet ¢ Caffeine ¢ Amantadine ¢ Bacitracin-Neomycin- ¢ Cincalcet 30 mg tablet Polymyxin B ¢ Calcipotriene ¢ Ambrisentan ¢ Ciprofloxacin ¢ Baclofen ¢ Calcipotriene-Betamethasone ¢ Amcinonide ¢ Ciprofloxacin-Dexamethasone ¢ Balsalazide ¢ Calcitonin injection ¢ Amiloride ¢ Ciprofloxacin-Hydrocortisone ¢ Becaplermin ¢ Calcitonin nasal spray ¢ Aminocaproic ¢ Citalopram ¢ Beclomethasone ¢ Calcitriol ¢ Aminophylline ¢ Belladonna-Opium ¢ Calcium acetate ¢ = Tier 1 ¢= Tier 2 ¢ = Tier 3 ¢ = Tier 4 ¢ Citalopram 20mg, 40mg tablet ¢ Denosumab 120 mg/1.7 ml ¢ Doxycycline suspension ¢ Estradiol Vaginal Ring ¢ Citric acid injection ¢ Dronabinol ¢ Estradiol Vaginal Tablet ¢ Clarithromycin ¢ Desipramine ¢ Dronedarone ¢ Estramustine ¢ Clemastine ¢ Desloratadine ¢ Duloxetine ¢ Estrogens conjugated ¢ Clindamycin ¢ Desmopressin ¢ Dutasteride ¢ Estropipate ¢ Clindamycin-Benzoyl peroxide ¢ Desonide ¢ Dyphylline ¢ Eszopiclone ¢ Desoximetasone ¢ Clindamycin-Tretinoin E ¢ Etanercept 25 mg injection ¢ Clobetasol ¢ Desvenlafaxine ¢ Echothiophate ¢ Etanercept 50 mg/ml injection ¢ Clocortolone ¢ Desvenlafaxine 100mg tablet ¢ Econazole ¢ Ethacrynic acid ¢ Clomipramine ¢ Dexamethasone ¢ Efavirenz ¢ Ethambutol ¢ Clonazepam ¢ Dexlansoprazole ¢ Efavirenz-Emtricitabine-Tenofovir HCR Ethinyl estradiol-Drospirenone ¢ Clonidine tablet ¢ Dexmethylphenidate ¢ Eletriptan HCR Ethinyl estradiol-Ethynodiol ¢ Clonidine suspension ¢ Dextroamphetamine ¢ Eltrombopag diacetate ¢ Clopidogrel ¢ Dextromethorphan-Quinidine ¢ Elvitegravir-Cobicistat- ¢ Ethionamide ¢ Clorazepate HCR Diaphragm Emtricitabine-Tenofovir ¢ Ethosuximide ¢ Clotrimazole ¢ Diazepam ¢ Emedastine ¢ Ethotoin ¢ Clotrimazole-Betamethasone ¢ Diazoxide ¢ Empagliflozin ¢ Alcohol (Ethanol) 70% Lock ¢ Clozapine ¢ Diclofenac ¢ Emtricitabine ¢ Etidronate ¢ Codeine ¢ Diclofenac gel ¢ Emtricitabine-Rilpivirine- ¢ Etodolac ¢ Colchicine ¢ Dicloxacillin Tenofovir ¢ Etoposide ¢ Colchicine-Probenecid ¢ Dicyclomine ¢ Emtricitabine-Tenofovir ¢ Etravirine ¢ Colesevelam ¢ Didanosine ¢ Enalapril ¢ Everolimus ¢ Colestipol ¢ Diethylpropion ¢ Enalapril suspension ¢ Exemestane ¢ Collagenase ¢ Difenoxin-Atropine ¢ Enfuvirtide ¢ Exenatide ACA Condoms: Female ¢ Diflorasone ¢ Enoxaparin ¢ Ezetimibe ACA Contraceptive sponge ¢ Diflunisal ¢ Entacapone ¢ Ezogabine ¢ Corticotropin ¢ Difluprednate ¢ Entecavir F ¢ Cortisone ¢ Digoxin ¢ Entecavir solution ¢ Famciclovir ¢ Crizotinib ¢ Digoxin solution ¢ Enzalutamide ¢ Famotidine Suspension ¢ Cromolyn ¢ Dihydroergotamine ¢ Epinastine ¢ Febuxostat ¢ Crotamiton ¢ Diltiazem ¢ Epinephrine ¢ Felbamate ¢ Cyclobenzaprine ¢ Dimethyl fumarate ¢ Epinephrine injection ¢ Felodipine ¢ Cyclophosphamide ¢ Diphenhydramine-Lidocaine- ¢ Eplerenone ¢ Fenofibrate ¢ Cycloserine Aluminum hydroxide- ¢ Epoetin ¢ Fenoprofen Magnesium hydroxide- ¢ Eprosartan ¢ Fentanyl ¢ Cyclosporine ophthalmic and Simethicone solution ¢ Ergocalciferol ACA Ferrous sulfate ¢ Diphenoxylate-Atropine ¢ Cyclosporine capsule (by prescription/legend) ¢ Fesoterodine ¢ Dipyridamole ¢ Cyproheptadine ACA Ergocalciferol (over the counter) ¢ Fidaxomicin ¢ Disopyramide ¢ Cysteamine ¢ Ergoloid ¢ Filgrastim injection ¢ Disopyramide controlled release ¢ Ergotamine ¢ Filgrastim Solution Prefilled D ¢ Disulfiram ¢ Dabigatran ¢ Ergotamine-Caffeine Syringe ¢ Divalproex ¢ Dalfampridine ¢ Erlotinib ¢ Finasteride ACA Docusate sodium ¢ Danazol ¢ Erythromycin tablet, ophthalmic ¢ Fingolimod ¢ Dofetilide ¢ Dantrolene ointment, topical solution ¢ Flavoxate ¢ Dolasetron ¢ Dapagliflozin ¢ Erythromycin suspension ¢ Flecainide ¢ Dolutegravir ¢ Dapsone ¢ Escitalopram ¢ Fluconazole ¢ Donepezil ¢ Darifenacin ¢ Esomeprazole ¢ Flucytosine ¢ Dornase ¢ Darunavir ¢ Esterified estrogens ¢ Fludrocortisone ¢ Dorzolamide ¢ Dasatinib ¢ Esterified estrogens- ¢ Fluocinolone ¢ Dorzolamide-Timolol Methyltestosterone ¢ Deferasirox ¢ Fluocinonide ¢ Doxazosin ¢ Esterified estrogens- ¢ Deferiprone ¢ Fluorometholone suspension ¢ Doxepin Methyltestosterone ¢ Delavirdine 1.2mg-2.5mg tablet
Load more

Recommended publications
  • Carbamate Pesticides Aldicarb Aldicarb Sulfoxide Aldicarb Sulfone
    Connecticut General Statutes Sec 19a-29a requires the Commissioner of Public Health to annually publish a list setting forth all analytes and matrices for which certification for testing is required. Connecticut ELCP Drinking Water Analytes Revised 05/31/2018 Microbiology Total Coliforms Fecal Coliforms/ E. Coli Carbamate Pesticides Legionella Aldicarb Cryptosporidium Aldicarb Sulfoxide Giardia Aldicarb Sulfone Carbaryl Physicals Carbofuran Turbidity 3-Hydroxycarbofuran pH Methomyl Conductivity Oxamyl (Vydate) Minerals Chlorinated Herbicides Alkalinity, as CaCO3 2,4-D Bromide Dalapon Chloride Dicamba Chlorine, free residual Dinoseb Chlorine, total residual Endothall Fluoride Picloram Hardness, Calcium as Pentachlorophenol CaCO3 Hardness, Total as CaCO3 Silica Chlorinated Pesticides/PCB's Sulfate Aldrin Chlordane (Technical) Nutrients Dieldrin Endrin Ammonia Heptachlor Nitrate Heptachlor Epoxide Nitrite Lindane (gamma-BHC) o-Phosphate Metolachlor Total Phosphorus Methoxychlor PCB's (individual aroclors) Note 1 PCB's (as decachlorobiphenyl) Note 1 Demands Toxaphene TOC Nitrogen-Phosphorus Compounds Alachlor Metals Atrazine Aluminum Butachlor Antimony Diquat Arsenic Glyphosate Barium Metribuzin Beryllium Paraquat Boron Propachlor Cadmium Simazine Calcium Chromium Copper SVOC's Iron Benzo(a)pyrene Lead bis-(2-ethylhexyl)phthalate Magnesium bis-(ethylhexyl)adipate Manganese Hexachlorobenzene Mercury Hexachlorocyclopentadiene Molybdenum Nickel Potassium Miscellaneous Organics Selenium Dibromochloropropane (DBCP) Silver Ethylene Dibromide (EDB)
    [Show full text]
  • Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity
    molecules Review Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity Babiker M. El-Haj 1,* and Samrein B.M. Ahmed 2 1 Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, University of Science and Technology of Fujairah, Fufairah 00971, UAE 2 College of Medicine, Sharjah Institute for Medical Research, University of Sharjah, Sharjah 00971, UAE; [email protected] * Correspondence: [email protected] Received: 6 February 2020; Accepted: 7 April 2020; Published: 22 April 2020 Abstract: Alkyl moieties—open chain or cyclic, linear, or branched—are common in drug molecules. The hydrophobicity of alkyl moieties in drug molecules is modified by metabolic hydroxy functionalization via free-radical intermediates to give primary, secondary, or tertiary alcohols depending on the class of the substrate carbon. The hydroxymethyl groups resulting from the functionalization of methyl groups are mostly oxidized further to carboxyl groups to give carboxy metabolites. As observed from the surveyed cases in this review, hydroxy functionalization leads to loss, attenuation, or retention of pharmacologic activity with respect to the parent drug. On the other hand, carboxy functionalization leads to a loss of activity with the exception of only a few cases in which activity is retained. The exceptions are those groups in which the carboxy functionalization occurs at a position distant from a well-defined primary pharmacophore. Some hydroxy metabolites, which are equiactive with their parent drugs, have been developed into ester prodrugs while carboxy metabolites, which are equiactive to their parent drugs, have been developed into drugs as per se.
    [Show full text]
  • Prevention and Management of Intravesical BCG-Related Lower Urinary Tract Symptoms with Prophylactic Pentosan Polysulphate In
    Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms with Prophylactic Pentosan Polysulphate in Patients with Non-Muscle-Invasive Bladder Cancer: A Randomized Controlled Trial Samer Shamout, Simon Tanguay, Maurice Anidjar, Lysanne Campeau CQI Research Grant 2017 INTRODUCTION METHODS / INTERVENTIONS PATIENT IMPACT Study Design • Bacillus Calmette-Guerin (BCG) remains the most effective • Phase 2, double-blind, randomized, placebo-controlled, parallel-group • Improve patient experience by identifying predictor markers prophylactic treatment of intermediate and high-risk non- study rendering patients at higher risk of developing BCG-related muscle invasive bladder cancer. • Multicentre trial involving two partner sites: (Jewish General Hospital, LUTS. McGill University Health Centre) • 30 to 60% of bladder cancer patients experienced systemic • This will guide patient counselling before treatment to inform Outcomes them about associated risks and benefits of the BCG and local adverse events of variable severity following Primary outcomes (change from baseline to end of treatment): treatment. intravesical BCG therapy • Mean change in number of urgency episodes/24hr (3-day bladder diary) • Only 16 to 29% of patients completed all the three-year BCG • Mean change in ICIQ-LUTSqol score • We will determine the role of prophylactic PPS to prevent these treatment regimen. • Mean change in OAB-V8 score LUTS from occurring, particularly if patients are considered at Secondary outcomes (change from baseline to end of treatment): higher risk, and therefore improve patient experience. • Guidelines recommend medications, such as oxybutynin • Mean change in VAS score only phenazopyridine, and propantheline bromide for short term • Mean change in urinary inflammatory markers (TRAIL, IFN, IL-2, IL-10) • The improvement measurements are validated in the symptomatic relief.
    [Show full text]
  • Optum Essential Health Benefits Enhanced Formulary PDL January
    PENICILLINS ketorolac tromethamineQL GENERIC mefenamic acid amoxicillin/clavulanate potassium nabumetone amoxicillin/clavulanate potassium ER naproxen January 2016 ampicillin naproxen sodium ampicillin sodium naproxen sodium CR ESSENTIAL HEALTH BENEFITS ampicillin-sulbactam naproxen sodium ER ENHANCED PREFERRED DRUG LIST nafcillin sodium naproxen DR The Optum Preferred Drug List is a guide identifying oxacillin sodium oxaprozin preferred brand-name medicines within select penicillin G potassium piroxicam therapeutic categories. The Preferred Drug List may piperacillin sodium/ tazobactam sulindac not include all drugs covered by your prescription sodium tolmetin sodium drug benefit. Generic medicines are available within many of the therapeutic categories listed, in addition piperacillin sodium/tazobactam Fenoprofen Calcium sodium to categories not listed, and should be considered Meclofenamate Sodium piperacillin/tazobactam as the first line of prescribing. Tolmetin Sodium Amoxicillin/Clavulanate Potassium LOW COST GENERIC PREFERRED For benefit coverage or restrictions please check indomethacin your benefit plan document(s). This listing is revised Augmentin meloxicam periodically as new drugs and new prescribing LOW COST GENERIC naproxen kit information becomes available. It is recommended amoxicillin that you bring this list of medications when you or a dicloxacillin sodium CARDIOVASCULAR covered family member sees a physician or other penicillin v potassium ACE-INHIBITORS healthcare provider. GENERIC QUINOLONES captopril ANTI-INFECTIVES
    [Show full text]
  • 4% Citanest® Plain Dental (Prilocaine Hydrochloride Injection, USP) for Local Anesthesia in Dentistry
    4% Citanest® Plain Dental (Prilocaine Hydrochloride Injection, USP) For Local Anesthesia in Dentistry Rx only DESCRIPTION 4% Citanest Plain Dental (prilocaine HCI Injection, USP), is a sterile, non-pyrogenic isotonic solution that contains a local anesthetic agent and is administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The quantitative composition is shown in Table 1. 4% Citanest Plain Dental contains prilocaine HCl, which is chemically designated as propanamide, N-(2- methyl-phenyl) -2- (propylamino)-, monohydrochloride and has the following structural formula: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. The specific quantitative composition is shown in Table 1. TABLE 1. COMPOSITION Product Identification Formula (mg/mL) Prilocaine HCl pH 4% Citanest® Plain Dental 40.0 6.0 to 7.0 Note: Sodium hydroxide or hydrochloric acid may be used to adjust the pH of 4% Citanest Plain Dental Injection. CLINICAL PHARMACOLOGY Mechanism of Action: Prilocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. Onset and Duration of Action: When used for infiltration injection in dental patients, the time of onset of anesthesia averages less than 2 minutes with an average duration of soft tissue anesthesia of approximately 2 hours. Based on electrical stimulation studies, 4% Citanest Plain Dental Injection provides a duration of pulpal anesthesia of approximately 10 minutes in maxillary infiltration injections. In clinical studies, this has been found to provide complete anesthesia for procedures lasting an average of 20 minutes. When used for inferior alveolar nerve block, the time of onset of 4% Citanest Plain Dental Injection averages less than three minutes with an average duration of soft tissue anesthesia of approximately 2 ½hours.
    [Show full text]
  • Lindane Shampoo Reference Number: CP.PMN.09 Effective Date: 11.01.06 Last Review Date: 08.20 Line of Business: Medicaid Revision Log
    Clinical Policy: Lindane Shampoo Reference Number: CP.PMN.09 Effective Date: 11.01.06 Last Review Date: 08.20 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description Lindane is an ectoparasiticide and ovicide effective against Pediculus humanus capitis (head lice), Pthirus pubis (crab lice), and their ova. FDA Approved Indication(s) Lindane Shampoo is indicated for the treatment of head lice (infestations of Pediculus humanus capitis), crab lice (infestations of Pthirus pubis), and their ova only in patients who cannot tolerate other approved therapies, or have failed treatment with other approved therapies. Policy/Criteria Provider must submit documentation (such as office chart notes, lab results or other clinical information) supporting that member has met all approval criteria. It is the policy of health plans affiliated with Centene Corporation® that Lindane shampoo is medically necessary when the following criteria are met: I. Initial Approval Criteria A. Head Lice (must meet all): 1. Diagnosis of Pediculus capitis (head lice); 2. Failure of two preferred agents indicated for head lice (see Appendix B for examples), at least one of which was used within the past 60 days, unless ALL preferred agents for head lice are contraindicated or clinically significant adverse effects are experienced; 3. Request does not exceed 1 bottle (60 mL) per treatment course. Approval duration: 14 days B. Crab Lice (must meet all): 1. Diagnosis of Phthirus pubis (crab lice); 2. Failure of pyrethrins/piperonyl butoxide AND permethrin 1% cream, used in last 60 days, unless both are contraindicated or clinically significant adverse effects are experienced; 3.
    [Show full text]
  • 3-Local-Anesthetics.Pdf
    Overview • Local anesthetics produce a transient and reversible loss of sensation (analgesia) in a circumscribed region of the body without loss of consciousness. • Normally, the process is completely reversible. • Local anesthetics are generally classified as either esters or amides and are usually linked to: – a lipophilic aromatic group – to a hydrophilic, ionizable tertiary (sometimes secondary) amine. • Most are weak bases with pKa ( 8 – 9), and at physiologic pH they are primarily in the charged, cationic form. • The potency of local anesthetics is positively correlated with their lipid solubility, which may vary 16-fold, and negatively correlated with their molecular size. • These anesthetics are selected for use on the basis of: 1. the duration of drug action • Short: 20 min • Intermediate: 1—1.5 hrs • Long: 2—4 hrs 2. effectiveness at the administration site 3. potential for toxicity Mechanism of action Local anesthetics act by blocking sodium channels and the conduction of action potentials along sensory nerves. • Blockade is voltage dependent and time dependent. a. At rest, the voltage-dependent sodium (Na+) channels of sensory nerves are in the resting (closed) state. • Following the action potential the Na+ channel becomes active (open) and then converts to an inactive (closed) state that is insensitive to depolarization. • Following repolarization of the plasma membrane there is a slow reversion of channels from the inactive to the resting state, which can again be activated by depolarization. • During excitation the cationic charged form of local anesthetics interacts preferentially with the inactivated state of the Na+ channels on the inner aspect of the sodium channel to block sodium current and increase the threshold for excitation.
    [Show full text]
  • AHFS Pharmacologic-Therapeutic Classification System
    AHFS Pharmacologic-Therapeutic Classification System Abacavir 48:24 - Mucolytic Agents - 382638 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Acitretin 84:92 - Skin and Mucous Membrane Agents, Abaloparatide 68:24.08 - Parathyroid Agents - 317036 Aclidinium Abatacept 12:08.08 - Antimuscarinics/Antispasmodics - 313022 92:36 - Disease-modifying Antirheumatic Drugs - Acrivastine 92:20 - Immunomodulatory Agents - 306003 4:08 - Second Generation Antihistamines - 394040 Abciximab 48:04.08 - Second Generation Antihistamines - 394040 20:12.18 - Platelet-aggregation Inhibitors - 395014 Acyclovir Abemaciclib 8:18.32 - Nucleosides and Nucleotides - 381045 10:00 - Antineoplastic Agents - 317058 84:04.06 - Antivirals - 381036 Abiraterone Adalimumab; -adaz 10:00 - Antineoplastic Agents - 311027 92:36 - Disease-modifying Antirheumatic Drugs - AbobotulinumtoxinA 56:92 - GI Drugs, Miscellaneous - 302046 92:20 - Immunomodulatory Agents - 302046 92:92 - Other Miscellaneous Therapeutic Agents - 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous - Adapalene 84:92 - Skin and Mucous Membrane Agents, Acalabrutinib 10:00 - Antineoplastic Agents - 317059 Adefovir Acamprosate 8:18.32 - Nucleosides and Nucleotides - 302036 28:92 - Central Nervous System Agents, Adenosine 24:04.04.24 - Class IV Antiarrhythmics - 304010 Acarbose Adenovirus Vaccine Live Oral 68:20.02 - alpha-Glucosidase Inhibitors - 396015 80:12 - Vaccines - 315016 Acebutolol Ado-Trastuzumab 24:24 - beta-Adrenergic Blocking Agents - 387003 10:00 - Antineoplastic Agents - 313041 12:16.08.08 - Selective
    [Show full text]
  • Comparison of Efficacy of Combination of 2% Ketoconazole
    Open Access Original Article Comparison of Topical Treatments in Pityriasis Versicolor Pak Armed Forces Med J 2018; 68 (6): 1725-30 COMPARISON OF EFFICACY OF COMBINATION OF 2% KETOCONAZOLE SOLUTION WASH AND TOPICAL 1% CLOTRIMAZOLE WITH TOPICAL 1% CLOTRIMAZOLE ALONE IN CASES OF PITYRIASIS VERSICOLOR Ayesha Anwar, Naeem Raza, Najia Ahmed, Hyder Ali Awan* Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan, *King Abdul Aziz Naval Base, Jubail, Saudia Arabia ABSTRACT Objective: Comparison of efficacy of combination comprising 2% ketoconazole solution wash plus topical 1% clotrimazole versus topical 1% clotrimazole alone in management of patients with Pityriasis versicolor. Study Design: Randomized controlled trial. Place and Duration of Study: Dermatology department, Pak Emirates Military Hospital Rawalpindi, from Oct 2016 to Apr 2017. Material and Methods: Sixty patients of Pityriasis versicolor, both male and female were included in study. Diagnosis of Pityriasis versicolor was made clinically and confirmed microscopically by examining skin scrapings for fungal hyphae. Patients with concomitant systemic illnesses or those who had received anti-fungal in last three months were excluded from study. Random number tables were used to allocate patients to the two treatment groups. Group A received 2% ketoconazole shampoo twice per week for four weeks plus topical 1% clotrimazole twice daily application for 2 weeks. Group B received only topical therapy with 1% clotrimazole cream applied twice daily for 2 weeks. Assessment of treatment efficacy was done by clinical examination of patient and microscopy of skin scrapping for fungal hyphaedone at baseline and at end of study (4 weeks of treatment). A negative clinical examination and negative skin scrapping for fungal hyphae was considered effective therapeutic response.
    [Show full text]
  • Impact of Tamsulosin, Tolterodine and Drug-Combination On
    African Journal of Urology (2017) 23, 28–32 African Journal of Urology Official journal of the Pan African Urological Surgeon’s Association web page of the journal www.ees.elsevier.com/afju www.sciencedirect.com Original article Impact of Tamsulosin, Tolterodine and drug-combination on the outcomes of lower urinary tract symptoms secondary to post-ureteroscopy ureteral stent: A prospective randomized controlled clinical study a b,∗ a a O. Abdelkader , K. Mohyelden , M.H. Sherif , A.H. Metwaly , b c d a H. Aldaqadossi , A. Shelbaya , H. Khairy , A. Elnashar a Department of Urology, Suez Canal University, Ismailia, Egypt b Department of Urology, Fayoum University, Fayoum, Egypt c Student Hospital, Cairo University, Cairo, Egypt d Department of Urology, Cairo University, Cairo, Egypt Received 17 March 2016; received in revised form 23 June 2016; accepted 23 June 2016 Available online 18 November 2016 KEYWORDS Abstract Anticholinergics; Objectives: To compare the role of alpha-blocker (Tamsulosin) monotherapy, anticholinergic (Tolterodine) ␣-Adrenergic blockers; monotherapy or combination of both drugs versus analgesics in improving post-ureteroscopy (URS) lower Ureter stent; urinary tract symptoms related to double-J ureteral stent. Ureteroscopy Patients and methods: Between January 2009 and June 2013, 160 consecutive patients with ureteric stones were included in this study at 2 tertiary care centers’. Patients were randomized into 4 groups; group A (n = 40) received 0.4 mg Tamsulosin once a day, group B (n = 40) received 4 mg Tolterodine once a day, group C (n = 40) received Tamsulosin 0.4 mg and Tolterodine 4 mg once a day and group D (n = 40) as a control group, received placebo once a day.
    [Show full text]
  • Antifungals, Topical
    Therapeutic Class Overview Antifungals, Topical INTRODUCTION The topical antifungals are available in multiple dosage forms and are indicated for a number of fungal infections and related conditions. In general, these agents are Food and Drug Administration (FDA)-approved for the treatment of cutaneous candidiasis, onychomycosis, seborrheic dermatitis, tinea corporis, tinea cruris, tinea pedis, and tinea versicolor (Clinical Pharmacology 2018). The antifungals may be further classified into the following categories based upon their chemical structures: allylamines (naftifine, terbinafine [only available over the counter (OTC)]), azoles (clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, oxiconazole, sertaconazole, sulconazole), benzylamines (butenafine), hydroxypyridones (ciclopirox), oxaborole (tavaborole), polyenes (nystatin), thiocarbamates (tolnaftate [no FDA-approved formulations]), and miscellaneous (undecylenic acid [no FDA-approved formulations]) (Micromedex 2018). The topical antifungals are available as single entity and/or combination products. Two combination products, nystatin/triamcinolone and Lotrisone (clotrimazole/betamethasone), contain an antifungal and a corticosteroid preparation. The corticosteroid helps to decrease inflammation and indirectly hasten healing time. The other combination product, Vusion (miconazole/zinc oxide/white petrolatum), contains an antifungal and zinc oxide. Zinc oxide acts as a skin protectant and mild astringent with weak antiseptic properties and helps to
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]